Reuters logo
BRIEF-Uniqure presents new preclinical data on AMT-130 in Huntington's disease
2017年4月26日 / 上午11点23分 / 7 个月前

BRIEF-Uniqure presents new preclinical data on AMT-130 in Huntington's disease

April 26 (Reuters) - Uniqure NV

* Uniqure presents new preclinical data on AMT-130 in Huntington’s disease

* One-Time administration of AMT-130 demonstrates for first time efficacy in large animal model

* Ind-Enabling toxicology study to commence in 2H 2017

* Uniqure NV - to commence toxicology study in non-human primates later this year, which co expects will support ind application for AMT-130 in 2018 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below